Pathogenicity and Drug resistance of Human Pathogens
portes grátis
Pathogenicity and Drug resistance of Human Pathogens
Mechanisms and Novel Approaches
Fatima, Zeeshan; Hameed, Saif
Springer Verlag, Singapore
12/2019
378
Dura
Inglês
9789813294486
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
Chapter 1. Pathogenicity and Drug resistance in Mycobacterium tuberculosis.- Chapter 1.1. Overview of tuberculosis pathogenesis.- Chapter 1.2. Response of Mycobacterium Tuberculosis to pH stress.- Chapter 1.3. Recent advances in Diagnosis of Tuberculosis.- Chapter 1.4. Molecular basis of Drug Resistance in Mycobacteria.- Chapter 1.5. Eliminating Mycobacterial persisters: novel targets for anti-TB therapy.- Chapter 1.6. Roadmap for the eradication of MDR-TB.- Chapter 2. Candida infections and therapeutic strategies.- Chapter 2.1. Fungal diseases and their treatment: a holistic approach.- Chapter 2.2. Anti-Candida therapeutics: mechanisms, resistance and safer phytomedicinal approaches.- Chapter 2.3. Mitochondria and drug resistance in Candida.- Chapter 2.4. Mechanism of Anti-Fungal for cutaneous infections: preventive potential, mechanism and treatment.- Chapter 3. Malarial parasite biology.- Chapter 3.1. Drug targets in Malarial parasites.- Chapter 3.2. Pathogenic mechanism and signaling pathways in Plasmodium.- Chapter 3.3. Mechanism of Drug Resistance in Plasmodium.- Chapter 3.4. Novel antimalarial drug targets.- Chapter 3.5. Novel therapeutic targets in malaria.- Chapter 4. Emerging Viral Diseases.- Chapter 4.1. Hepatitis C Virus and innate interferon response.- Chapter 4.1.1. Pathogen biology.- Chapter 4.1.2. Drug resistance.- Chapter 4.1.3. Novel drug targets and therapeutic strategies.- Chapter 4.2. Epidemiological trends and current challenges in Ebola.- Chapter 4.2.1. Pathogen biology.- Chapter 4.2.2.Drug resistance.- Chapter 4.2.3. Novel drug targets and therapeutic strategies.- Chapter 4.3. Prions diseases: a concern for mankind.- Chapter 5. Translational Research in Human Microbes.- Chapter 5.1. Harnessing microbiota as anti-infectives.- Chapter 5.2. Human microbiome and malignancy: principles, mechanisms and challenges.- Chapter 5.3. Current and future perspectives of nanobiotechnology: in combating microbial pathogenesis.- Chapter 5.4. Microbes in reproductive tract system: inferences from microbial world.- Chapter 5.5. miRNAs in infectious diseases.- Chapter 5.6. Application of bioinformatics in combating infectious diseases.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Chapter 1. Pathogenicity and Drug resistance in Mycobacterium tuberculosis.- Chapter 1.1. Overview of tuberculosis pathogenesis.- Chapter 1.2. Response of Mycobacterium Tuberculosis to pH stress.- Chapter 1.3. Recent advances in Diagnosis of Tuberculosis.- Chapter 1.4. Molecular basis of Drug Resistance in Mycobacteria.- Chapter 1.5. Eliminating Mycobacterial persisters: novel targets for anti-TB therapy.- Chapter 1.6. Roadmap for the eradication of MDR-TB.- Chapter 2. Candida infections and therapeutic strategies.- Chapter 2.1. Fungal diseases and their treatment: a holistic approach.- Chapter 2.2. Anti-Candida therapeutics: mechanisms, resistance and safer phytomedicinal approaches.- Chapter 2.3. Mitochondria and drug resistance in Candida.- Chapter 2.4. Mechanism of Anti-Fungal for cutaneous infections: preventive potential, mechanism and treatment.- Chapter 3. Malarial parasite biology.- Chapter 3.1. Drug targets in Malarial parasites.- Chapter 3.2. Pathogenic mechanism and signaling pathways in Plasmodium.- Chapter 3.3. Mechanism of Drug Resistance in Plasmodium.- Chapter 3.4. Novel antimalarial drug targets.- Chapter 3.5. Novel therapeutic targets in malaria.- Chapter 4. Emerging Viral Diseases.- Chapter 4.1. Hepatitis C Virus and innate interferon response.- Chapter 4.1.1. Pathogen biology.- Chapter 4.1.2. Drug resistance.- Chapter 4.1.3. Novel drug targets and therapeutic strategies.- Chapter 4.2. Epidemiological trends and current challenges in Ebola.- Chapter 4.2.1. Pathogen biology.- Chapter 4.2.2.Drug resistance.- Chapter 4.2.3. Novel drug targets and therapeutic strategies.- Chapter 4.3. Prions diseases: a concern for mankind.- Chapter 5. Translational Research in Human Microbes.- Chapter 5.1. Harnessing microbiota as anti-infectives.- Chapter 5.2. Human microbiome and malignancy: principles, mechanisms and challenges.- Chapter 5.3. Current and future perspectives of nanobiotechnology: in combating microbial pathogenesis.- Chapter 5.4. Microbes in reproductive tract system: inferences from microbial world.- Chapter 5.5. miRNAs in infectious diseases.- Chapter 5.6. Application of bioinformatics in combating infectious diseases.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
